APA (7th ed.) Citation

Rahil Sadat Shahtaheri, Nahid Hatam, & Zahra Goudarzi. (2018). Cost-utility analysis of interferon beta-1a (Avonex and Cinnovex) for relapsing remitting multiple sclerosis. Tehran University of Medical Sciences.

Chicago Style (17th ed.) Citation

Rahil Sadat Shahtaheri, Nahid Hatam, and Zahra Goudarzi. Cost-utility Analysis of Interferon Beta-1a (Avonex and Cinnovex) for Relapsing Remitting Multiple Sclerosis. Tehran University of Medical Sciences, 2018.

MLA (9th ed.) Citation

Rahil Sadat Shahtaheri, et al. Cost-utility Analysis of Interferon Beta-1a (Avonex and Cinnovex) for Relapsing Remitting Multiple Sclerosis. Tehran University of Medical Sciences, 2018.